Product Code: ETC5266815 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Drug Discovery Services Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Drug Discovery Services Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Drug Discovery Services Market - Industry Life Cycle |
3.4 Canada Drug Discovery Services Market - Porter's Five Forces |
3.5 Canada Drug Discovery Services Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.6 Canada Drug Discovery Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Canada Drug Discovery Services Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Canada Drug Discovery Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Rise in research and development activities in pharmaceutical industry |
4.2.3 Growing prevalence of chronic diseases requiring novel drug discovery solutions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with drug discovery services |
4.3.3 Limited access to advanced technologies and expertise |
5 Canada Drug Discovery Services Market Trends |
6 Canada Drug Discovery Services Market Segmentations |
6.1 Canada Drug Discovery Services Market, By Process |
6.1.1 Overview and Analysis |
6.1.2 Canada Drug Discovery Services Market Revenues & Volume, By Target Selection, 2021-2031F |
6.1.3 Canada Drug Discovery Services Market Revenues & Volume, By Target Validation, 2021-2031F |
6.1.4 Canada Drug Discovery Services Market Revenues & Volume, By Hit-to-Lead identification, 2021-2031F |
6.1.5 Canada Drug Discovery Services Market Revenues & Volume, By Lead Optimization, 2021-2031F |
6.1.6 Canada Drug Discovery Services Market Revenues & Volume, By Candidate Validation, 2021-2031F |
6.2 Canada Drug Discovery Services Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Drug Discovery Services Market Revenues & Volume, By Chemistry Services, 2021-2031F |
6.2.3 Canada Drug Discovery Services Market Revenues & Volume, By Biology Services, 2021-2031F |
6.3 Canada Drug Discovery Services Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Canada Drug Discovery Services Market Revenues & Volume, By Pharmaceutical & Biotechnology companies, 2021-2031F |
6.3.3 Canada Drug Discovery Services Market Revenues & Volume, By Academic Institutes, 2021-2031F |
6.3.4 Canada Drug Discovery Services Market Revenues & Volume, By Others, 2021-2031F |
7 Canada Drug Discovery Services Market Import-Export Trade Statistics |
7.1 Canada Drug Discovery Services Market Export to Major Countries |
7.2 Canada Drug Discovery Services Market Imports from Major Countries |
8 Canada Drug Discovery Services Market Key Performance Indicators |
8.1 Number of new drug discoveries and patents filed |
8.2 Percentage increase in research funding allocated to drug discovery services |
8.3 Adoption rate of innovative technologies in drug discovery process |
9 Canada Drug Discovery Services Market - Opportunity Assessment |
9.1 Canada Drug Discovery Services Market Opportunity Assessment, By Process, 2021 & 2031F |
9.2 Canada Drug Discovery Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Canada Drug Discovery Services Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Canada Drug Discovery Services Market - Competitive Landscape |
10.1 Canada Drug Discovery Services Market Revenue Share, By Companies, 2024 |
10.2 Canada Drug Discovery Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |